SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+1.73%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.59B
AUM Growth
+$1.59B
(-6.3%)
Cap. Flow
+$23.5M
Cap. Flow
% of AUM
1.48%
Top 10 Holdings %
Top 10 Hldgs %
51.2%
Holding
86
New
16
Increased
31
Reduced
15
Closed
11
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$66.9M |
| 2 |
Stryker
SYK
|
$65.7M |
| 3 |
RAPP
Rapport Therapeutics
RAPP
|
$45.4M |
| 4 |
Align Technology
ALGN
|
$29.7M |
| 5 |
Axsome Therapeutics
AXSM
|
$25M |
Top Sells
| 1 |
Merck
MRK
|
$85.9M |
| 2 |
Incyte
INCY
|
$75.6M |
| 3 |
argenx
ARGX
|
$58.8M |
| 4 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$45.5M |
| 5 |
Insulet
PODD
|
$32.1M |
Sector Composition
| 1 | Healthcare | 99.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NextCure
NXTC
$13.3M
| $4.25M | 0.22% |
2,671,856
| – | – |
|
52
Erasca
ERAS
$406M
| $4.01M | 0.21% |
+1,699,528
| New | +$4.01M |
|
53
Phibro Animal Health
PAHC
$1.55B
| $3.97M | 0.21% |
+237,009
| New | +$3.97M |
|
54
Baxter International
BAX
$12.1B
| $3.94M | 0.2% |
117,769
+97,769
| +489% | +$3.27M |
|
55
Avantor
AVTR
$8.74B
| $2.99M | 0.16% |
141,045
-91,401
| -39% | -$1.94M |
|
56
Teleflex
TFX
$5.57B
| $2.87M | 0.15% |
13,649
+1,507
| +12% | +$317K |
|
57
Masimo
MASI
$7.43B
| $2.54M | 0.13% |
20,161
+161
| +0.8% | +$20.3K |
|
58
Bolt Biotherapeutics
BOLT
$9.29M
| $2.07M | 0.11% |
2,754,437
| – | – |
|
59
Inspire Medical Systems
INSP
$2.53B
| $1.34M | 0.07% |
10,000
+1,901
| +23% | +$254K |
|
60
Disc Medicine
IRON
$2.14B
| $1.32M | 0.07% |
29,256
+23,083
| +374% | +$1.04M |
|
61
Perspective Therapeutics
CATX
$251M
| $1.32M | 0.07% |
132,089
-298,016
| -69% | +$888K |
|
62
Zimmer Biomet
ZBH
$20.8B
| $1.15M | 0.06% |
+10,630
| New | +$1.15M |
|
63
LivaNova
LIVN
$3.09B
| $1.13M | 0.06% |
20,602
+146
| +0.7% | +$8K |
|
|
IMTXW
64
DELISTED
Immatics N.V. Warrants
IMTXW
| $933K | 0.05% |
348,731
+32,382
| +10% | +$86.6K |
|
65
Avidity Biosciences
RNA
$6.12B
| $875K | 0.05% |
+21,425
| New | +$875K |
|
|
IMA
66
ImageneBio, Inc. Common Stock
IMA
$153M
| $631K | 0.03% |
382,616
| – | – |
|
67
Amylyx Pharmaceuticals
AMLX
$877M
| $569K | 0.03% |
299,691
-7,038
| -2% | -$13.4K |
|
68
Astria Therapeutics
ATXS
$394M
| $552K | 0.03% |
+60,692
| New | +$552K |
|
69
PDS Biotechnology
PDSB
$60.6M
| $418K | 0.02% |
142,635
| – | – |
|
70
Pulmonx
LUNG
$67.6M
| $382K | 0.02% |
+60,246
| New | +$382K |
|
71
Kyverna Therapeutics
KYTX
$161M
| $359K | 0.02% |
47,850
+37,850
| +379% | +$284K |
|
72
Structure Therapeutics
GPCR
$1.14B
| $350K | 0.02% |
8,915
+182
| +2% | +$7.15K |
|
|
INBX
73
DELISTED
Inhibrx, Inc. Common Stock
INBX
| – | – |
-1,302,645
| Closed | -$45.5M |
|
|
SWAV
74
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-35,000
| Closed | -$11.4M |
|
|
FUSN
75
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| – | – |
-157,172
| Closed | -$3.35M |
|